GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » Gross Profit

Synthetic MR AB (XSAT:SYNT) Gross Profit : kr96.40 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB Gross Profit?

Synthetic MR AB's gross profit for the three months ended in Mar. 2024 was kr19.47 Mil. Synthetic MR AB's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was kr96.40 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Synthetic MR AB's gross profit for the three months ended in Mar. 2024 was kr19.47 Mil. Synthetic MR AB's Revenue for the three months ended in Mar. 2024 was kr17.78 Mil. Therefore, Synthetic MR AB's Gross Margin % for the quarter that ended in Mar. 2024 was 109.49%.

Synthetic MR AB had a gross margin of 109.49% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 12 years, the highest Gross Margin % of Synthetic MR AB was 148.59%. The lowest was 105.03%. And the median was 107.34%.


Synthetic MR AB Gross Profit Historical Data

The historical data trend for Synthetic MR AB's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB Gross Profit Chart

Synthetic MR AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.38 52.23 62.80 73.58 94.37

Synthetic MR AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.44 22.64 22.95 31.34 19.47

Competitive Comparison of Synthetic MR AB's Gross Profit

For the Health Information Services subindustry, Synthetic MR AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthetic MR AB's Gross Profit Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's Gross Profit falls into.



Synthetic MR AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Synthetic MR AB's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=89.213 - -5.159
=94.37

Synthetic MR AB's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=17.784 - -1.687
=19.47

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr96.40 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Synthetic MR AB's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=19.47 / 17.784
=109.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Synthetic MR AB  (XSAT:SYNT) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Synthetic MR AB had a gross margin of 109.49% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Synthetic MR AB Gross Profit Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthetic MR AB (XSAT:SYNT) Business Description

Traded in Other Exchanges
N/A
Address
Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (XSAT:SYNT) Headlines

From GuruFocus

Third Avenue Management Comments on Syntel

By Holly LaFon 07-02-2013

Syntel Joins Google Cloud Partner Program

By Marketwired Marketwired 03-26-2018

A Solid Pick at a Fair Price

By Jae Jun Jae Jun 03-31-2015

RM LAW Announces Investigation of Syntel, Inc.

By PRNewswire PRNewswire 07-26-2018

Syntel to Present at Investor Conference

By Marketwired Marketwired 05-10-2018

Gurus Find Hot Information Technology Stocks

By James Li James Li 06-10-2016